Japan approves Arthrocare's arthroscopy system:
This article was originally published in Clinica
Executive Summary
Arthrocare is to begin marketing its Coblation line of arthroscopy products in Japan following approval there. Coblation technology uses radiofrequency energy to remove tissue. The process is significantly cooler than electro- or laser-surgery and is designed to improve precision and accuracy, causing minimal damage to the surrounding tissue, said the company which is based in Sunnyvale, California. Over 200,000 arthroscopy procedures take place in Japan each year.
You may also be interested in...
Pharma Can Pursue Claims Against Providers For 340B Duplicate Discounts In Medicaid Managed Care, HRSA Says
The statement, which is part of a final rule on the 340B administrative dispute resolution process, could facilitate manufacturer efforts to seek repayments from hospitals in such cases.
The Aspirin Test For AI?
US FDA Commissioner Robert Califf tells Congress that regulators don’t have to know how artificial intelligence works in medicine, but must make very sure it actually does work.
Mary Beth Clarke, CDER Exec Programs Office Director And Generic User Fee Shepherd, Will Retire
Clarke helped launch GDUFA I and negotiate GDUFA II, chaired the CDER Executive Committee and oversaw many other programs in the US FDA’s drugs center.